Perseon Medical (NSDQ:PRSN) said yesterday that it closed the sale of its assets this week and reverted to its former name, BSD Medical, as part of the deal. The $4.35 million sale, which closed August 22, was part of the Chapter 11 bankruptcy proceedings for Perseon, which makes the MicroThermX microwave ablation system for treating soft tissue tumors. The device can […]
BSD Medical Corp.
BSD Medical pursues Taiwanese clearance
BSD Medical Corp. (NSDQ:BSDM) said it’s pursuing Taiwanese marketing clearance for its BSD 2000 hyperthermia system.
BSD Medical posts 100% Q3 sales growth | Wall Street Beat
Shares of BSD Medical Corp. (NSDQ:BSDM) are up today after the medical device company reported a more than 102% increase in fiscal 3rd-quarter sales.
Salt Lake City-based BSD said the increase was largely due to increased sales of its MicroThermX microwave ablation device for soft tissue, according to a press release.
InspireMD raises $23M for MGuard stent | Wall Street Beat
BSD launches rectal cancer treatment study
BSD Medical Corp. (NSDQ:BSDM) initiated its Phase I/II HyRec-Trial, evaluating its BSD-2000 Hyperthermia System to treat patients with locally recurrent rectal cancer.
The clinical trial, which has been approved by the German Cancer Society, will enroll 59 patients to evaluate the feasibility and the efficacy of adding hyperthermia to a multimodal treatment regimen, the company said.
Losses gape, sales narrow for BSD Medical
BSD Medical Corp. (NSDQ:BSDM) saw its losses increase by more than 50% during fiscal 2012, as sales decreased by nearly 32%.
The Salt Lake City-based medical device company reported losses of $8.0 million, or 27¢ per share, on sales of $2.1 million during the 12 months ended August 31.
The news sent BSDM shares down 5.9% to $1.93 apiece as of about noon today.
Angels in America: Early-stage investment rebounds | Wall Street Beat
Angel investors started to come out of their shells during the first half of the year with angel investments up more than 3% compared with H1 2011, according to research out of the University of New Hampshire, and medical device companies took the lion’s share of the backing.
The medical device and equipment sector grabbed 24% of total angel investment during the first six months of the year, according to a study from UNH’s Center for Venture Research.
Sony picks up 11% Olympus stake for $640M | Wall Street Beat
Sony Corp. (TYO:6758) plans to become the largest shareholder in Olympus (TYO:7733) with a $642 million investment that will give it an 11% stake in Olympus.
Edwards Lifesciences insiders keep selling | Wall Street Beat
Edwards Lifesciences (NYSE:EW) insiders aren’t buying, and they haven’t been for several months, according to a report.
Although insiders have been selling shares, 3 of them in the last week, none have purchased any since at least April, SeekingAlpha reported.
MAKO’s plunge may be good news for buyers | Wall Street Beat
Mako Surgical (NSDQ:MAKO) has had a tough month on Wall Street, with shares having lost 45% since the end of April, but not everyone is running for the hills.
Earlier this week a company director, Frederick Moll, picked up another 5,000 shares at $24.15 each, representing the 1st insider buy on the open market since late last year.
Biomet’s Q3 losses widen on modest top-line growth | Earnings Roundup
Third-quarter losses mounted for orthopedic device giant Biomet Inc. as its top line enjoyed only modest growth.
Warsaw, Ind.-based Biomet posted losses of $16.5 million, on sales of $708.9 million, during the 3 months ended Feb. 29, 2012, compared with losses of $11.6 million, on sales of $678 million, during the same period last year.
Adjusted for 1-time expenses, the company’s net income for Q3 came to $55.1 million, compared to adjusted profits of $212.8 million during Q3 2011.
